People with diabetes, especially type 2 diabetes, tend to carry extra weight around their midsection because of a self-reinforcing cycle between insulin resistance and a particular type of abdominal fat called visceral fat. This isn’t just the soft, pinchable layer under the skin. It’s a deeper fat that wraps around the liver, intestines, and other organs, and it behaves very differently from fat stored on the hips or thighs. But visceral fat is only part of the story. Diabetes medications, hormonal shifts, digestive complications, disrupted sleep, and even changes in gut bacteria all push the belly outward in ways that are worth understanding separately.
Visceral Fat and the Insulin Resistance Loop
The core reason diabetics develop prominent bellies involves a feedback loop between visceral fat and insulin resistance. Visceral fat is metabolically hyperactive. Unlike the fat stored under your skin, visceral fat releases a large volume of free fatty acids and inflammatory molecules directly into the portal vein, the blood vessel that feeds straight into the liver. That flood of fatty acids interferes with how the liver processes insulin, which worsens insulin resistance throughout the body.1PubMed. Impact of visceral adipose tissue on liver metabolism. Part I: heterogeneity of adipose tissue and functional properties of visceral adipose tissue More insulin resistance, in turn, promotes further fat storage in the abdomen. The body’s cells are not responding well to insulin, so the pancreas pumps out more of it. Elevated insulin drives fat deposition, and the visceral compartment seems to be a preferred destination.
This link is not just theoretical. Increased visceral fat is an established risk factor for metabolic disorders including insulin resistance and type 2 diabetes, while subcutaneous fat stored on the hips and thighs does not carry the same risk.2PubMed Central. Metabolic alterations following visceral fat removal and expansion: Beyond anatomic location The relationship runs in both directions: visceral fat makes diabetes worse, and diabetes makes visceral fat accumulate faster. That’s why the belly seems to grow even when someone with diabetes hasn’t changed what they eat.
Chronic Inflammation Keeps the Cycle Going
Visceral fat doesn’t just sit there storing energy. In people with obesity, immune cells flood into the fat tissue and set up what amounts to a low-grade, permanent inflammatory state. Macrophages, a type of immune cell, can make up as much as 40% of all cells in obese adipose tissue. These macrophages shift into an inflammatory mode and pump out signaling molecules that further impair insulin signaling.3PubMed Central. Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes
At the same time, the body’s production of adiponectin, a hormone that normally helps keep inflammation in check and improves insulin sensitivity, drops as visceral fat increases. People with type 2 diabetes tend to have lower adiponectin levels than people of the same weight without diabetes, suggesting something specific about the diabetic metabolic environment suppresses this protective hormone.4PubMed. Adiponectin and inflammation: consensus and controversy The result is a triple hit: more visceral fat triggers more inflammation, more inflammation worsens insulin resistance, and falling adiponectin removes a natural brake on the whole process.
Cortisol and Hormonal Drivers
Cortisol, the body’s main stress hormone, is another piece of the puzzle. People with obesity, particularly those with large amounts of visceral fat, tend to have an overactive stress-hormone axis and increased cortisol production at the tissue level.5PubMed Central. Cortisol dysregulation in obesity-related metabolic disorders Cortisol promotes fat storage in the abdominal region specifically. This is why conditions involving chronic cortisol excess, like Cushing’s syndrome, produce a characteristic “apple-shaped” body.
For people with diabetes, stress and poor sleep can elevate cortisol chronically. Chronic stress exposure through the body’s glucocorticoid system is increasingly linked to obesity development, with cortisol affecting how fat cells form and where fat gets deposited.6PubMed Central. Glucocorticoids and HPA axis regulation in the stress-obesity connection: A comprehensive overview of biological, physiological and behavioural dimensions The takeaway is that the hormonal environment in diabetes actively steers new fat toward the belly rather than distributing it evenly.
Medications That Add Inches
Several medications commonly prescribed for diabetes contribute to weight gain, and the added weight often lands around the midsection. Insulin therapy is the most well-known culprit. Insulin-related weight gain presents a genuine dilemma for doctors treating type 2 diabetes, because the treatment that controls blood sugar can simultaneously worsen the abdominal fat that drives the disease.7PubMed Central. Insulin therapy and type 2 diabetes: management of weight gain This tradeoff frequently leads to delays in starting insulin, even when blood sugar levels clearly warrant it. Sulfonylureas, an older class of oral diabetes drugs, can also promote weight gain.
On the other side of the medication spectrum, newer drugs called GLP-1 receptor agonists (the class that includes semaglutide and liraglutide) appear to actively reduce visceral fat. A meta-analysis found these medications meaningfully decreased both visceral fat and fat stored in the liver compared to other treatments.8PubMed Central. The effects of GLP-1 receptor agonists on visceral fat and liver ectopic fat in an adult population with or without diabetes and nonalcoholic fatty liver disease: A systematic review and meta-analysis These drugs also reduce triglycerides, decrease fat tissue inflammation, and limit ectopic fat deposits in organs where fat shouldn’t accumulate.9PubMed. Mechanisms of GLP-1 Receptor Agonist-Induced Weight Loss: A Review of Central and Peripheral Pathways in Appetite and Energy Regulation The rapid rise in prescriptions for these medications partly reflects how important visceral fat reduction has become as a treatment goal, not just blood sugar control.
It’s Not Always Fat
Not every big belly in diabetes is caused by visceral fat. Gastroparesis, a condition where the stomach empties abnormally slowly, is a recognized complication of diabetes. It causes bloating, distension, nausea, and a visibly swollen abdomen that has nothing to do with fat storage. The exact cause isn’t fully understood, but proposed mechanisms include damage to the vagus nerve from chronic high blood sugar, disruption of the specialized pacemaker cells in the stomach wall, and oxidative stress.10PubMed. Diabetic gastroparesis: An overview of pathogenesis, clinical presentation and novel therapies, with a focus on ghrelin receptor agonists Symptoms range from mild discomfort after eating to severe episodes of vomiting that require hospitalization.
Bacterial overgrowth in the small intestine, known as SIBO, is another contributor to abdominal distension in people with diabetes. A systematic review estimated that roughly 29% of people with diabetes have SIBO.11PubMed Central. The prevalence of small intestinal bacterial overgrowth in diabetes mellitus: a systematic review and meta-analysis When bacteria proliferate in the small intestine where they don’t belong, they ferment food prematurely, producing gas and bloating that makes the abdomen protrude. Research has also found that people with diabetes who test positive for SIBO tend to have worse blood sugar control, with higher average glucose levels than those without it.12PubMed Central. Association between small intestinal bacterial overgrowth and beta-cell function of type 2 diabetes So if you have diabetes and experience persistent bloating that feels different from simple weight gain, the cause may be digestive rather than metabolic.
The Gut Microbiome Connection
Beyond SIBO, the broader composition of gut bacteria appears to be linked to how much visceral fat a person carries. Research using CT scans to measure visceral fat and genetic sequencing to identify gut bacteria found that visceral fat area had the largest number of correlations with bacterial species compared to any other obesity-related measurement, including waist circumference and BMI.13Computational and Structural Biotechnology Journal. A metagenome-wide association study of gut microbiome and visceral fat accumulation Certain bacterial species were enriched in people with high visceral fat, with E. coli showing the strongest positive correlation.14PubMed Central. Gut Microbiome Alterations in Patients With Visceral Obesity Based on Quantitative Computed Tomography
People with type 1 diabetes show a related pattern. Endotoxins, inflammatory molecules produced by certain gut bacteria, correlate positively with visceral fat mass, BMI, and triglyceride levels in this population.15Scientific Reports. Endotoxins are associated with visceral fat mass in type 1 diabetes Whether the altered gut bacteria are causing visceral fat to accumulate or whether visceral fat is reshaping the gut environment isn’t settled. But the connection is strong enough that researchers consider the microbiome a potential intervention target for reducing abdominal obesity in diabetes.
Why Men and Women Carry It Differently
Sex hormones play a major role in where fat gets deposited. Testosterone promotes fat cell formation in the abdomen while inhibiting it in the hips and thighs. Estrogen does roughly the opposite, favoring fat storage in the lower body. This hormonal difference means men with diabetes are more prone to accumulating visceral fat, while premenopausal women are more likely to store fat subcutaneously.16PubMed Central. Gender Differences of Visceral Fat Area to Hip Circumference Ratio for Insulin Resistance
However, that doesn’t mean women are protected. A large longitudinal study found that while men generally have more visceral fat, the risk of developing type 2 diabetes from increasing visceral fat is actually stronger in women than in men. The optimal visceral fat cutoff for predicting diabetes was substantially lower in women (about 86 square centimeters on imaging) compared to men (about 130 square centimeters).17Diabetes & Metabolism Journal. Sex Differences of Visceral Fat Area and Visceral-to-Subcutaneous Fat Ratio for the Risk of Incident Type 2 Diabetes Mellitus In practical terms, a woman doesn’t need to develop as large a belly as a man for the metabolic consequences to kick in. Imaging studies also show that women with type 2 diabetes tend to have higher liver fat than men, even when men have larger visceral fat deposits overall.18PubMed. Sex Differences in the Associations Between Visceral Adiposity and Hepatic Insulin Clearance in Type 2 Diabetes Mellitus: A Quantitative CT Study The metabolic harm of abdominal fat is not one-size-fits-all.
Sleep Loss Feeds the Belly
Poor sleep doesn’t just make you tired. It reshapes where your body stores fat. Even a few nights of restricted sleep reduce insulin sensitivity through spikes in cortisol, growth hormone shifts, and elevated free fatty acids. When sleep restriction becomes chronic, it sustains ectopic fat deposits, the kind of fat lodged around and within organs.19IAA Journal of Applied Sciences. Circadian Rhythm Disruption, Sleep Disorders, and Their Role in Obesity‑Linked Diabetes
A study comparing adults with poor sleep quality to those who slept well found that poor sleepers had significantly more visceral fat, even though the two groups didn’t differ in total body fat.20PubMed Central. Sleep Quality is Differentially Related to Adiposity in Adults That’s a striking finding: sleep quality specifically affected belly fat without changing fat mass elsewhere. For someone with diabetes already prone to visceral fat accumulation, chronically bad sleep adds fuel to the fire. And diabetes itself often disrupts sleep through nighttime blood sugar swings, frequent urination, and neuropathy, creating yet another vicious circle.
Type 1 Diabetes and Abdominal Fat
The association between diabetes and belly fat isn’t limited to type 2. People with type 1 diabetes, especially those on intensive insulin therapy, can develop significant visceral fat. Research has found that visceral fat index and trunk fat mass are strongly linked to insulin resistance in type 1 diabetes, with visceral fat being a significant independent predictor of metabolic syndrome in this group.21PubMed Central. Body composition and metabolic syndrome in patients with type 1 diabetes The growing phenomenon sometimes called “double diabetes,” where someone with type 1 develops insulin resistance typically associated with type 2, is closely tied to this visceral fat accumulation.
The reasons partially overlap with type 2: exogenous insulin promotes fat storage, and the inflammatory cascade from visceral fat worsens insulin sensitivity. But there are unique factors too. People with type 1 diabetes tend to have higher circulating endotoxins from gut bacteria, and these endotoxins correlate with visceral fat mass and systemic inflammation markers.15Scientific Reports. Endotoxins are associated with visceral fat mass in type 1 diabetes The result is that type 1 diabetes, once thought of primarily as a disease of thin, young people, can produce the same characteristic belly shape when the metabolic environment shifts.
Why Your Tape Measure Matters More Than Your Scale
Standard weight-based measurements like BMI tell you how heavy you are relative to your height, but they say nothing about where the fat sits. Two people with identical BMIs can have vastly different amounts of visceral fat and wildly different metabolic risk profiles. For people with diabetes, waist-centered measurements are far more informative.
A study in a Cameroonian population found that waist circumference was a better discriminator of undiagnosed diabetes than BMI, hip circumference, or waist-to-hip ratio. Each standard-deviation increase in waist circumference raised the odds of diabetes by about 30%, whereas the same increase in BMI barely budged the odds.22PubMed. Body mass index, waist circumference, hip circumference, waist-hip-ratio and waist-height-ratio: which is the better discriminator of prevalent screen-detected diabetes in a Cameroonian population? Combining multiple measurements didn’t improve prediction beyond waist circumference alone.
The waist-to-height ratio, calculated by simply dividing your waist measurement by your height, may be even more useful. A longitudinal study found that waist-to-height ratio had the highest accuracy for predicting who would develop diabetes over a four-year follow-up, outperforming both waist circumference and BMI.23PubMed Central. Association of Waist-Height Ratio with Diabetes Risk: A 4-Year Longitudinal Retrospective Study A systematic review also found that waist-to-height ratio and waist circumference were significantly better than BMI at predicting dangerous cholesterol patterns and metabolic syndrome in people with diabetes.24PubMed Central. Comparative Evaluation of Waist-to-Height Ratio and BMI in Predicting Adverse Cardiovascular Outcome in People With Diabetes: A Systematic Review Even in type 1 diabetes, waist-to-height ratio and waist circumference are the best estimators of visceral fat percentage, regardless of sex.25Scientific Reports. Waist-height ratio and waist are the best estimators of visceral fat in type 1 diabetes
The practical rule of thumb is straightforward: if your waist circumference is more than half your height, your visceral fat is likely in a range that raises metabolic risk. It’s a far cheaper and more accessible screening tool than a CT scan, and for people with diabetes, it tracks the type of fat that matters most.
An Evolutionary Footnote
One theory for why the human body is so prone to storing visceral fat and developing insulin resistance in the first place traces back to survival pressures. Insulin resistance may have evolved as an adaptation to periodic starvation, essentially a metabolic switch that diverted glucose away from muscles and toward the brain and fat stores during times of food scarcity.26PubMed Central. Evolutionary origins of insulin resistance: a behavioral switch hypothesis In an environment of constant calorie abundance, that ancient survival mechanism backfires, promoting chronic fat storage in the abdomen and the cascade of metabolic problems that follow. The “big stomach” of diabetes, in other words, may be an ancient feature of human biology running unchecked in a modern food environment.